Abstract
Purpose
Merkel cell carcinoma (MCC) is a rare aggressive neuroendocrine tumor of the skin mainly found in elderly white patients. Due to its poor prognosis with distant metastases in up to 33% and local recurrence in 25–33% and a 5 year disease-specific survival of 64% (1–2) its early diagnosis and appropriate treatment is mandatory.
Methods
The study is an exceptional clinical case of a patient with a large inoperable MCC unable to be treated according to treatment guidelines due to her old age. We review the literature addressing treatment options.
Results
The patient was treated with palliative definitive radiotherapy to her large MCC of the left lower leg. She showed a rapid clinical response to four palliative radiation doses of 7 Gy each, necrosis of tumor mass and persistent clearing at a follow-up of 32 weeks. Our patient was very unusual in terms of her extensive MCC and her rapid and complete response to palliative radiotherapy lasting for 6 months at present.
Conclusions
As MCC is an aggressive tumor, best survival is achieved with early diagnosis in a localized stage and prompt adequate surgery and further stage-adjusted treatment. Thus, the differential diagnosis of MCC should not be dismissed in a reddish nodule on the leg, and every excision should be submitted to pathology. In accordance with the literature we demonstrate here that definitive radiotherapy is an effective treatment option for inoperable MCC, which in this individual patient produced necrosis of the extensive tumor mass after only four palliative doses.
Similar content being viewed by others
References
Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG (2005) Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 23:2300–2309
Connelly TJ, Cribier B, Brown TJ, Yanguas I (2000) Complete spontaneous regression of Merkel cell carcinoma: a review of the ten reported cases. Dermatol Surg 26:853–856
Decker RH, Wilson LD (2006) Role of radiotherapy in the management of Merkel cell carcinoma of the skin. J Natl Compr Canc Netw 4:713–718
Fernandez-Figueras MT, Puig L, Musulen E, Gilaberte M, Lerma E, Serrano S, Ferrandiz C, Ariza A (2007) Expression profiles associated with aggressive behavior in Merkel cell carcinoma. Mod Pathol 20:90–101
Friedlaender MM, Rubinger D, Rosenbaum E, Amir G, Siguencia E (2002) Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine. Transplantation 73:1849–1850
Heath ML, Nghiem P (2007) Merkel cell carcinoma: if no breslow, then what? J Surg Oncol 95:614–615
Howard RA, Dores GM, Curtis RE, Anderson WF, Travis LB (2006) Merkel cell carcinoma and multiple primary cancers. Cancer Epidemiol Biomarkers Prev 15:1545–1549
Kanitakis J, Euvrard S, Chouvet B, Butnaru AC, Claudy A (2006a) Merkel cell carcinoma in organ-transplant recipients: report of two cases with unusual histological features and literature review. J Cutan Pathol 33:686–694
Kanitakis J, Joly MO, Chouvet B, Euvrard S, Claudy A (2006b) Merkel cell carcinoma in immunocompetent and organ-transplant recipients do not harbor HPV. Eur J Dermatol 16:445–446
Koljonen V, Tukiainen E, Haglund C, Böhling T (2006) Proliferative activity detected by Ki67 correlates with poor outcome in Merkel cell carcinoma. Histopathology 49:551–553
Lau PPL, Lui PCW (2006) Fine needle aspiration diagnosis of metastatic Merkel cell carcinoma with multinucleated bizarre tumour cells in a post-renal transplant patient. Pathology 38:456–458
Leibovitch I, Davis G, Huilgol SC, Crompton J, James CL, Selva D (2006) An unusual presentation of periocular Merkel cell carcinoma. J Cutan Pathol 33(Suppl. 2):39–41
Lewis KG, Weinstock MA, Weaver AL, Otley CC (2006) Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol 142:693–700
Malani AK,Gupta C, Singh J, Ammar H (2006) Bronchus-associated B-cell lymphoma occurring after radiation and chemotherapy for head and neck Merkel cell carcinoma. Ann Hematol 85:815–816
Manor E, Bellaiche E, Bodner L (2006) Cytogenetic findings of a primary Merkel cell carcinoma. Cancer Genet Cytogenet 169:78–80
McAfee WJ, Morris CG, Mendenhall CM, Werning JW, Mendenhall NP, Mendenhall WM (2005) Merkel cell carcinoma: treatment and outcomes. Cancer 104:1761–1764
McNiff JM, Cowper SE, Lazova R, Subtil A, Glusac EJ (2005) CD56 staining in Merkel cell carcinoma and natural killer-cell lymphoma: magic bullet, diagnostic pitfall, or both? J Cutan Pathol 32:541–545
Meier G, Waldherr C, Herrmann R, Maecke H, Mueller-Brand J, Pless M (2004) Successful targeted radiotherapy with 90Y-DOTATOC in a patient with Merkel cell carcinoma. A case report. Oncology 66:160–163
Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, Cheney RT, Glass F, Grekin RC, Grichnik JM, Johnson TM, Kessinger A, Lee NY, Lessin S, Lydiatt DD, Margolis LW, Nehal KS, Nghiem P, Oseroff AR, Rosenberg EW, Shaha AR, Siegle RJ (2006) Merkel cell carcinoma. J Natl Compr Canc Netw 4:704–712
Mortier L, Mirabel X, Fournier C, Piette F, Lartigau E (2003) Radiotherapy alone for primary Merkel cell carcinoma. Arch Dermatol 139:1587–1590
Pectasides D, Pectasides M, Psyrri A, Koumarianou A, Xiros N, Pectasides E, Gaglia A, Lianos E, Papaxoinis G, Lampadiari V, Economopoulos T (2006) Cisplatin-based chemotherapy for Merkel cell cardinoma of the skin. Cancer Invest 24:780–785
Plaza JA, Suster S (2006) The Toker tumor spectrum of morphologic features in primary neuroendocrine carcinomas of the skin (Merkel cell carcinoma). Ann Diagn Pathol 10:376–385
Poulsen M (2004) Merkel-cell carcinoma of the skin. Lancet Oncol 5:593–599
Poulsen MG, Rischin D, Porter I, Walpole E, Harvey J, Hamilton C, Keller J, Tripcony L (2006) Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? Int J Radiat Oncol Biol Phys 64:114–119
Sais G, Admella C, Soler T (2002) Spontaneous regression in primary cutaneous neuroendocrine (Merkel cell) carcinoma: a rare immune phenomenon? J Eur Acad Dermatol Venereol 16:82–83
Schwindl B, Meißner A, Giedl J, Klotz T (2006) Merkel cell carcinoma—a rarity in the urogenital tract. Onkologie 29:326–328
Shaw M, Warren S, Groben P, Gulley ML (2006) No evidence of Epstein-Barr virus association with Merkel cell carcinoma. J Cutan Pathol 33:624–628
Takenaka H, Kishimoto S, Shibagaki R, Nagata M, Yasuno H (1997) Merkel cell carcinoma with partial spontaneous regression. An immunohistochemical, ultrastructural, and TUNEL labeling study. Am J Dermatopathol 19:614–618
Toker C (1972) Trabecular carcinoma of the skin. Arch Derm 105:107–110
Tucci MG, Lucarini G, Giangiacomi M, Zizzi A, Criante P, Ricotti G, Biagini G (2006) Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinoma. J Eur Acad Dermatol Venereol 20:1220–1225
Veness MJ (2006) Merkel cell carcinoma (primary cutaneous neuroendocrine carcinoma): an overview on management. Australas J Dermatol 47:160–165
Veness MJ, Harris D (2007) Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers. Australas Radiol 51:12–20
Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK (1991) Merkel cell carcinoma. Prognosis and management. Arch Surg 126:1514–1519
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Strobel, ES., Feyer, P., Steingräber, M. et al. An unusual case of Merkel cell carcinoma. J Cancer Res Clin Oncol 134, 119–123 (2008). https://doi.org/10.1007/s00432-007-0257-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-007-0257-2